Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Matsubara

Showing results (121-130 of 191) with videos related to

Pageof 20
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 2, 2011
Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine greenShogo Inoue, Hiroaki Shiina, Naoko Arichi, et al.
European Urology|June 22, 2005
Urological retroperitoneoscopic surgery for patients with prior intra-abdominal surgeryKoji Mita, Masanobu Shigeta, Kazuaki Mutaguchi, et al.
International Urology and Nephrology|September 26, 2019
Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancerKenichiro Fukuoka, Jun Teishima, Hirotaka Nagamatsu, et al.
Japanese Journal of Clinical Oncology|August 8, 2018
Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinomaYuki Kohada, Tetsutaro Hayashi, Keisuke Goto, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 5, 2022
ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial CarcinomaGo Kobayashi, Tetsutaro Hayashi, Kazuhiro Sentani, et al.
Japanese Journal of Clinical Oncology|February 27, 2020
Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3Jun Teishima, Tetsutaro Hayashi, Hiroyuki Kitano, et al.
Molecular and Clinical Oncology|May 19, 2017
Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levelsKeisuke Goto, Hirotaka Nagamatsu, Jun Teishima, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2020
Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorsJun Teishima, Shogo Inoue, Tetsutaro Hayashi, et al.
Urologic Oncology|June 28, 2014
Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) methodShunsuke Shinmei, Kazuhiro Sentani, Tetsutaro Hayashi, et al.
Plos One|June 4, 2015
Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell LinesRyuhei Kanaoka, Akifumi Kushiyama, Yasuyuki Seno, et al.
Pageof 20

Showing results (121-130 of 191) with videos related to

Sort By:
Pageof 20
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 2, 2011
Identification of lymphatic pathway involved in the spreading of prostate cancer by fluorescence navigation approach with intraoperatively injected indocyanine greenShogo Inoue, Hiroaki Shiina, Naoko Arichi, et al.
European Urology|June 22, 2005
Urological retroperitoneoscopic surgery for patients with prior intra-abdominal surgeryKoji Mita, Masanobu Shigeta, Kazuaki Mutaguchi, et al.
International Urology and Nephrology|September 26, 2019
Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancerKenichiro Fukuoka, Jun Teishima, Hirotaka Nagamatsu, et al.
Japanese Journal of Clinical Oncology|August 8, 2018
Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinomaYuki Kohada, Tetsutaro Hayashi, Keisuke Goto, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|July 5, 2022
ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial CarcinomaGo Kobayashi, Tetsutaro Hayashi, Kazuhiro Sentani, et al.
Japanese Journal of Clinical Oncology|February 27, 2020
Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3Jun Teishima, Tetsutaro Hayashi, Hiroyuki Kitano, et al.
Molecular and Clinical Oncology|May 19, 2017
Body mass index as a classifier to predict biochemical recurrence after radical prostatectomy in patients with lower prostate-specific antigen levelsKeisuke Goto, Hirotaka Nagamatsu, Jun Teishima, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2020
Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitorsJun Teishima, Shogo Inoue, Tetsutaro Hayashi, et al.
Urologic Oncology|June 28, 2014
Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) methodShunsuke Shinmei, Kazuhiro Sentani, Tetsutaro Hayashi, et al.
Plos One|June 4, 2015
Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell LinesRyuhei Kanaoka, Akifumi Kushiyama, Yasuyuki Seno, et al.
Pageof 20